About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
KYMR
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Kymera Therapeutics GAAP EPS of -$0.25 beats by $0.06, revenue of $47.9M beats by $5.91M
- Kymera Therapeutics Q4 2023 Earnings Preview
- Kymera Therapeutics prices $275 million securities offering
- Kymera commences $250M public offering
- Kymera Therapeutics announces public offering of $250M shares of its stock
- Kymera stock dips 5% following BofA downgrade
- Kymera Therapeutics GAAP EPS of -$0.90 misses by $0.19, revenue of $4.73M misses by $11.24M
- Kymera Therapeutics GAAP EPS of -$0.67 beats by $0.06, revenue of $16.51M beats by $2.77M
- FDA grants orphan drug status to Kymera blood cancer drug KT-253
- Kymera climbs on data updates for three drug programs (update)
- Kymera Therapeutics appoints COO
- Kymera upgraded to outperform at Raymond James on improved risk/reward
- Kymera off 14% on quarterly results, lack of clarity on trial
- Kymera Therapeutics GAAP EPS of -$0.70 beats by $0.01, revenue of $9.5M misses by $4.65M
- Kymera Therapeutics GAAP EPS of -$0.60 beats by $0.03, revenue of $16.1M misses by $4.56M
- Kymera Therapeutics and X-Chem a expand existing partnership
- Kymera surges 30% as Sanofi plans to advance drug after promising data in skin disorders
- Kymera cut to Neutral at Credit Suisse on upcoming readout
- Kymera Therapeutics GAAP EPS of -$0.79 misses by $0.05, revenue of $9.54M misses by $6.4M
- Kymera KT-333 gets FDA orphan drug status for blood cancer subtype
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| September 1, 2021 | - / -0.2591 | - / 18.81M | |
| August 6, 2021 | -0.55 / -0.2591 | 18.52M / 18.81M | |
| June 2, 2021 | - / -0.1925 | - / 19.33M | |
| May 6, 2021 | -0.29 / -0.1483 | 18.7M / 19.05M | |
| March 11, 2021 | -0.29 / -0.0517 | 12.8M / 21.6M | |
| March 3, 2021 | -0.12 / -0.0517 | 18M / 21.6M | |
| November 5, 2020 | -0.39 / 0.7167 | 14.53M / 84M | |
| September 2, 2020 | -7.61 / - | 6.7M / - |
Beat! |
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25 | 40.43 | 42.06 |
42.06
|
40.24
|
181.47K | -4.4% | ||||
| Mar 24 | 42.29 | 41.43 |
42.30
|
40.63
|
151.31K | 3.02% | ||||
| Mar 23 | 41.05 | 42.45 |
43.58
|
40.90
|
228.35K | -4.09% | ||||
| Mar 22 | 42.80 | 40.76 |
43.09
|
40.56
|
219.09K | 5.42% | ||||
| Mar 21 | 40.60 | 43.20 |
43.22
|
40.40
|
395.10K | -6.21% | ||||
| Mar 18 | 43.29 | 41.26 |
43.48
|
40.36
|
939.29K | 4.36% | ||||
| Mar 17 | 41.48 | 38.01 |
41.49
|
38.01
|
606.80K | 7.74% | ||||
| Mar 16 | 38.50 | 36.52 |
38.55
|
36.13
|
427.11K | 7.96% | ||||
| Mar 15 | 35.66 | 37.44 |
37.53
|
34.51
|
585.02K | -3.2% | ||||
| Mar 14 | 36.84 | 38.75 |
39.31
|
36.27
|
389.04K | -4.14% | ||||
| Mar 11 | 38.43 | 40.36 |
41.15
|
38.42
|
296.94K | -2.98% | ||||
| Mar 10 | 39.61 | 38.73 |
40.94
|
37.54
|
361.70K | -1.3% | ||||
| Mar 9 | 40.13 | 37.70 |
40.35
|
37.07
|
549.83K | 10.67% | ||||
| Mar 8 | 36.26 | 35.47 |
38.17
|
34.28
|
436.64K | 2.72% | ||||
| Mar 7 | 35.30 | 36.40 |
37.00
|
35.11
|
356.96K | -1.64% | ||||
| Mar 4 | 35.89 | 37.08 |
37.97
|
35.44
|
293.88K | -4.9% | ||||
| Mar 3 | 37.74 | 39.50 |
39.50
|
36.97
|
359.85K | -3.48% | ||||
| Mar 2 | 39.10 | 39.16 |
39.50
|
38.31
|
235.27K | 1.48% | ||||
| Mar 1 | 38.53 | 39.44 |
41.59
|
38.06
|
231.76K | -3.09% | ||||
| Feb 28 | 39.76 | 39.60 |
41.13
|
38.75
|
279.79K | -0.77% | ||||